Description
Tri-Itra 65 SB (Itraconazole B.P. 65mg) is a cutting-edge antifungal capsule formulated with SUBA (Super Bio-Available) technology, which significantly enhances the absorption and dissolution of poorly soluble drugs. This innovative technology involves a solid dispersion of itraconazole in a polymer matrix, improving its bioavailability over conventional crystalline forms. As a result, Tri-Itra 65 SB delivers therapeutic effectiveness equivalent to a conventional 100 mg itraconazole capsule.
Itraconazole is known for its broad-spectrum antifungal properties, effectively treating a wide range of fungal infections such as aspergillosis, onychomycosis, and dermatophytosis. The SUBA technology ensures superior absorption, leading to better treatment outcomes, improved patient compliance, and higher acceptance compared to treatments like fluconazole.
Key Features:
- SUBA technology for enhanced bioavailability.
- Therapeutically equivalent to conventional 100 mg itraconazole capsules.
- Effective against a wide range of fungal infections.
- Improved patient compliance and better efficacy than fluconazole.
Indications:
- Dermatophyte infections
- Systemic fungal infections
- Onychomycosis
Tri-Itra 65 SB is designed for patients seeking an effective antifungal treatment with advanced bioavailability and quicker symptomatic relief.